Sweden · Delayed Price · Currency is SEK Medicover AB Statistics
Total Valuation
Medicover AB has a market cap or net worth of SEK 39.18 billion. The enterprise value is 54.28 billion.
| Market Cap | 39.18B |
| Enterprise Value | 54.28B |
Important Dates
The next estimated earnings date is Wednesday, November 5, 2025.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | Apr 30, 2025 |
Share Statistics
Medicover AB has 150.98 million shares outstanding. The number of shares has increased by 0.40% in one year.
| Current Share Class | 74.36M |
| Shares Outstanding | 150.98M |
| Shares Change (YoY) | +0.40% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 11.16% |
| Owned by Institutions (%) | 25.97% |
| Float | 50.84M |
Valuation Ratios
The trailing PE ratio is 80.51 and the forward PE ratio is 41.06. Medicover AB's PEG ratio is 0.57.
| PE Ratio | 80.51 |
| Forward PE | 41.06 |
| PS Ratio | 1.55 |
| PB Ratio | 7.23 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 22.30 |
| P/OCF Ratio | 12.47 |
| PEG Ratio | 0.57 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.13, with an EV/FCF ratio of 30.90.
| EV / Earnings | 111.98 |
| EV / Sales | 2.15 |
| EV / EBITDA | 16.13 |
| EV / EBIT | 43.86 |
| EV / FCF | 30.90 |
Financial Position
The company has a current ratio of 0.87, with a Debt / Equity ratio of 2.94.
| Current Ratio | 0.87 |
| Quick Ratio | 0.77 |
| Debt / Equity | 2.94 |
| Debt / EBITDA | 4.73 |
| Debt / FCF | 9.05 |
| Interest Coverage | 1.73 |
Financial Efficiency
Return on equity (ROE) is 7.68% and return on invested capital (ROIC) is 3.87%.
| Return on Equity (ROE) | 7.68% |
| Return on Assets (ROA) | 3.17% |
| Return on Invested Capital (ROIC) | 3.87% |
| Return on Capital Employed (ROCE) | 6.24% |
| Revenue Per Employee | 536,624 |
| Profits Per Employee | 10,312 |
| Employee Count | 47,256 |
| Asset Turnover | 1.04 |
| Inventory Turnover | 28.02 |
Taxes
In the past 12 months, Medicover AB has paid 171.98 million in taxes.
| Income Tax | 171.98M |
| Effective Tax Rate | 28.31% |
Stock Price Statistics
The stock price has increased by +40.73% in the last 52 weeks. The beta is 1.57, so Medicover AB's price volatility has been higher than the market average.
| Beta (5Y) | 1.57 |
| 52-Week Price Change | +40.73% |
| 50-Day Moving Average | 262.94 |
| 200-Day Moving Average | 236.37 |
| Relative Strength Index (RSI) | 49.81 |
| Average Volume (20 Days) | 49,994 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medicover AB had revenue of SEK 25.22 billion and earned 484.68 million in profits. Earnings per share was 3.22.
| Revenue | 25.22B |
| Gross Profit | 5.68B |
| Operating Income | 1.24B |
| Pretax Income | 607.53M |
| Net Income | 484.68M |
| EBITDA | 2.35B |
| EBIT | 1.24B |
| Earnings Per Share (EPS) | 3.22 |
Balance Sheet
The company has 998.40 million in cash and 15.90 billion in debt, giving a net cash position of -14.90 billion or -98.70 per share.
| Cash & Cash Equivalents | 998.40M |
| Total Debt | 15.90B |
| Net Cash | -14.90B |
| Net Cash Per Share | -98.70 |
| Equity (Book Value) | 5.42B |
| Book Value Per Share | 34.57 |
| Working Capital | -767.23M |
Cash Flow
In the last 12 months, operating cash flow was 3.14 billion and capital expenditures -1.38 billion, giving a free cash flow of 1.76 billion.
| Operating Cash Flow | 3.14B |
| Capital Expenditures | -1.38B |
| Free Cash Flow | 1.76B |
| FCF Per Share | 11.64 |
Margins
Gross margin is 22.52%, with operating and profit margins of 4.90% and 1.92%.
| Gross Margin | 22.52% |
| Operating Margin | 4.90% |
| Pretax Margin | 2.41% |
| Profit Margin | 1.92% |
| EBITDA Margin | 9.33% |
| EBIT Margin | 4.90% |
| FCF Margin | 6.97% |
Dividends & Yields
This stock pays an annual dividend of 1.64, which amounts to a dividend yield of 0.63%.
| Dividend Per Share | 1.64 |
| Dividend Yield | 0.63% |
| Dividend Growth (YoY) | 17.10% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 51.84% |
| Buyback Yield | -0.40% |
| Shareholder Yield | 0.23% |
| Earnings Yield | 1.24% |
| FCF Yield | 4.48% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medicover AB has an Altman Z-Score of 2.03 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.03 |
| Piotroski F-Score | 7 |